or Try an Advanced Search...

    Technical Analysis for CHRO - Chromocell Therapeutics Corporation

    Grade Last Price % Change Price Change
    F 1.77 -1.12% -0.02
    CHRO closed down 1.12 percent on Wednesday, May 1, 2024, on 16 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Very Strong N/A Down Up
    Historical CHRO trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Wide Bands Range Expansion -1.12%
    Up 3 Days in a Row Strength -1.12%
    1,2,3 Retracement Bearish Bearish Swing Setup 9.26%
    Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 9.26%
    Older End-of-Day Signals for CHRO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High 1 day ago
    Up 5% 1 day ago
    Up 3% 1 day ago
    Up 2% 1 day ago
    Up 1% 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    CHRO Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Chromocell Therapeutics Corporation, a clinical-stage biotech company, focuses on the discovery, development, and commercialization of new therapeutics to alleviate pain. The company intends to selectively target the sodium ion-channel known as NaV1.7, as well as other receptors in the NaV family. Its lead compound is CC8464, which is in Phase 2a clinical trials for use in the treatment of erythromelalgia, as well as for the treatment of eye pain and neuropathic pain. The company was founded in 2002 and is based in Freehold, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pain Neuropathic Pain Erythromelalgia Sodium Channel Blockers

    Is CHRO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Mar 21 Chromocell Announces Formal Launch of Eye Pain Treatment Program and Hiring of Dr. Simon Chandler
    Mar 18 Chromocell appoints Frank Knuettel as CEO, removing interim status
    Mar 18 Chromocell Names Frank Knuettel as Chief Executive Officer, Removing Interim Status Held Since July 2023
    Mar 12 Sidoti Events, LLC's Virtual March Small-Cap Conference
    Feb 27 Benuvia Operations, LLC and Chromocell Therapeutics Corp. Announce Strategic Partnership to Advance Healthcare Solutions
    Feb 21 Chromocell Therapeutics Announces Closing of Initial Public Offering for Gross Proceeds of $6.6 Million
    Feb 16 Chromocell stock down 11% following $7M IPO
    Feb 16 Chromocell Therapeutics prices upsized $6.6M IPO at $6 per share
    Feb 16 Chromocell Therapeutics Announces Pricing of Upsized $6.6 Initial Public Offering
    See more CHRO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.0
    52 Week Low 1.22
    Average Volume 25,637
    200-Day Moving Average 0.00
    50-Day Moving Average 2.70
    20-Day Moving Average 1.79
    10-Day Moving Average 1.56
    Average True Range 0.27
    RSI (14) 44.75
    ADX 53.58
    +DI 14.06
    -DI 24.18
    Chandelier Exit (Long, 3 ATRs) 1.77
    Chandelier Exit (Short, 3 ATRs) 2.03
    Upper Bollinger Bands 2.36
    Lower Bollinger Band 1.22
    Percent B (%b) 0.48
    BandWidth 63.55
    MACD Line -0.32
    MACD Signal Line -0.40
    MACD Histogram 0.0802
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.84
    Resistance 3 (R3) 1.84 1.82 1.83
    Resistance 2 (R2) 1.82 1.81 1.82 1.82
    Resistance 1 (R1) 1.80 1.80 1.79 1.79 1.82
    Pivot Point 1.78 1.78 1.77 1.78 1.78
    Support 1 (S1) 1.75 1.76 1.74 1.75 1.72
    Support 2 (S2) 1.73 1.75 1.73 1.72
    Support 3 (S3) 1.71 1.73 1.71
    Support 4 (S4) 1.70